一品紅(300723.SZ):發行可轉債募資總額由不超5.3億元調減為不超4.8億元
格隆匯 9 月 30日丨一品紅(300723.SZ)公佈,公司第二屆董事會第二十二次會議決議,審議通過《關於調減公司向不特定對象發行可轉換公司債券募集資金總額的議案》。
根據相關法律法規及規範性文件的要求,為確保公司此次向不特定對象發行可轉換公司債券的順利進行,同時根據公司2020年第二次臨時股東大會的授權,董事會同意將此次向不特定對象發行可轉換公司債券募集資金總額由“不超過5.3億元(含本數)”調減為“不超過4.8億元(含本數)”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.